COLGATE TOTAL ADVANCED HEALTH SENSITIVE TOOTHPASTE

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

SODIUM FLUORIDE; TRICLOSAN; SILICON DIOXIDE

から入手可能:

COLGATE-PALMOLIVE CANADA INC

ATCコード:

A01AA51

INN（国際名）:

SODIUM FLUORIDE, COMBINATIONS

投薬量:

0.243%; 0.3%; 5%

医薬品形態:

TOOTHPASTE

構図:

SODIUM FLUORIDE 0.243%; TRICLOSAN 0.3%; SILICON DIOXIDE 5%

投与経路:

DENTAL

パッケージ内のユニット:

85/170ML

処方タイプ:

OTC

治療領域:

DENTAL AGENTS

製品概要:

Active ingredient group (AIG) number: 0352996001; AHFS:

認証ステータス:

CANCELLED POST MARKET

承認日:

2019-08-01

製品の特徴

_ _
_ _
_Page 1 of 22_
PRODUCT MONOGRAPH
COLGATE TOTAL ADVANCED HEALTH SENSITVE
Triclosan, Sodium Fluoride, and Silicon Dioxide Toothpaste
0.3% Triclosan, 0.243% Sodium Fluoride, and 5% Silicon Dioxide
Anticaries – Antiplaque – Antigingivitis – Anticalculus-
Anti-Sensitivity
Colgate-Palmolive Canada Inc.
Two Morneau Sobeco Centre, 6
th
Floor
895 Don Mills Road
Toronto, Ontario
M3C 1W3
Date of Revision:
September 14, 2011
Control #: 142198
_ _
_ _
_Page 2 of 22_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................3
ADVERSE REACTIONS
....................................................................................................4
DOSAGE AND ADMINISTRATION
................................................................................4
OVERDOSAGE
..................................................................................................................4
ACTION AND CLINICAL PHARMACOLOGY
..............................................................5
STORAGE AND STABILITY
............................................................................................9
SPECIAL HANDLING INSTRUCTIONS
.........................................................................9
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................9
PART II: SCIENTIFIC INFORMATION
...............................................................................10
PHARMACEUTICAL INFORMATION
..........................................................................10
DETAILED PHARMACOLOGY
..................